Home » EU Agency Confirms Suspension of Merck Cholesterol Drug
EU Agency Confirms Suspension of Merck Cholesterol Drug
Europe’s drug regulator has confirmed it is suspending marketing authorizations for Merck’s cholesterol drug Tredaptive (niacin/laropiprant) in Europe after its failure in a major study raised safety concerns.
Reuters
Reuters
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May